Wolfe Research initiated coverage of Bruker with an Outperform rating and $80 price target. The combination of solid visibility on generating mid-single-digit/high-single-digit 2024 revenue growth, unique portfolio positioning to capitalize on durable secular tailwinds, a premier track record of scientific innovation, and a discount relative valuation position Bruker to Outperform, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on BRKR: